Sanofi R&D leader Houman Ashrafian to depart, Paulo Fontoura to take the reins
Sanofi's head of R&D Houman Ashrafian will leave the company, with Paulo Fontoura tapped to succeed him as Sanofi reshapes its research leadership.
Sanofi (NASDAQ: SNY; Euronext: SAN) is a global biopharmaceutical company with major franchises in immunology (Dupixent, partnered with Regeneron), vaccines (Beyfortus, Fluzone, Dengvaxia), rare disease (Genzyme-legacy Pompe, Fabry, MS), and a growing oncology pipeline. Sanofi has been reshaping its R&D portfolio toward immunology and rare disease while spinning off its consumer health unit.
Company Info
Recent News
Sanofi's head of R&D Houman Ashrafian will leave the company, with Paulo Fontoura tapped to succeed him as Sanofi reshapes its research leadership.
Formed by Sofinnova Partners and former Sanofi executive Frédéric Marrache, Bionyra Pharma emerged from stealth Monday with an initial focus in inflammatory bowel disease and atopic dermatitis.
Leadership Team
Chief Executive Officer
Careers & Job Openings